Posts

Showing posts with the label Speech

Prince Harry's speech at the UN has little in common with Mandela

In honor of the late president on his birthday, July 18 is observed as Nelson Mandela Day by the United Nations. This week someone had the less-than-bright idea to invite Prince Harry to deliver the keynote address. The United Nations exists as a symbol of the global human family. Yet Harry and his wife Meghan Markle are estranged from their own families, a division that deepens after an ill-timed spray on the Royal Family even as the Queen mourns her dying husband. Less generous but no less accurate, the United Nations exists so that countries that cannot solve anything individually, can come together to decide that nothing can be done collectively. By giving a Sunday sermon for the embodiment of royal privileges, the United Nations invites ridicule and ridicule by belittling a deadly serious issue and asserting that it is a non-serious organization that is increasingly out of purpose. While the Queen honors her privileged birthright with selfless service, duties and responsibilities

New computational model can detect cognitive impairment from audio recordings of neuropsychological tests

It takes a lot of time and money to diagnose Alzheimer’s disease. After running a lengthy face-to-face neuropsychological exam, the doctor must copy, review, and analyze each response in detail. But researchers at Boston University have developed a new tool that could automate the process and eventually allow it to move online. Their machine learning-powered computational model can detect cognitive impairment from audio recordings of neuropsychological-tests; no in-person appointment required. Their findings were published in Alzheimer’s & Dementia: Journal of the Alzheimer’s Association . “This approach brings us one step closer to early intervention,” said Ioannis Paschalidis, co-author of the paper and BU College of Engineering Distinguished Professor of Engineering. He said faster early detection of Alzheimer’s could prompt larger clinical trials that focus on individuals in the early stages of the disease and potentially enable clinical interventions that slow cognitive